Diet, body size, physical activity and risk of prostate cancer: An umbrella review of the evidence
- PMID: 27816833
- DOI: 10.1016/j.ejca.2016.09.026
Diet, body size, physical activity and risk of prostate cancer: An umbrella review of the evidence
Abstract
The existing literature on the relationship between diet, body size, physical activity and prostate cancer risk was summarised by the World Cancer Research Fund Continuous Update Project (CUP). An evaluation of the robustness of this evidence is required to help inform public health policy. The robustness of this evidence was evaluated using several criteria addressing evidence strength and validity, including the statistical significance of the random effects summary estimate and of the largest study in a meta-analysis, number of prostate cancer cases, between-study heterogeneity, 95% prediction intervals, small-study effects bias, excess significance bias and sensitivity analyses with credibility ceilings. A total of 248 meta-analyses were extracted from the CUP, which studied associations of 23 foods, 31 nutrients, eight indices of body size and three indices of physical activity with risk of total prostate cancer development, mortality or cancer development by stage and grade. Of the 176 meta-analyses using a continuous scale to measure the exposures, no association presented strong evidence by satisfying all the aforementioned criteria. Only the association of height with total prostate cancer incidence and mortality presented highly suggestive evidence with a 4% higher risk per 5 cm greater height (95% confidence interval, 1.03, 1.05). Associations for body mass index, weight, height, dietary calcium and spirits intake were supported by suggestive evidence. Overall, the association of diet, body size, physical activity and prostate cancer has been extensively studied, but no association was graded with strong evidence.
Keywords: Diet; Nutrition; Physical activity; Prostate cancer; Umbrella review.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Similar articles
-
Risk factors for prostate cancer: An umbrella review of prospective observational studies and mendelian randomization analyses.PLoS Med. 2024 Mar 15;21(3):e1004362. doi: 10.1371/journal.pmed.1004362. eCollection 2024 Mar. PLoS Med. 2024. PMID: 38489391 Free PMC article.
-
Adiposity and cancer at major anatomical sites: umbrella review of the literature.BMJ. 2017 Feb 28;356:j477. doi: 10.1136/bmj.j477. BMJ. 2017. PMID: 28246088 Free PMC article. Review.
-
Role of Diet in Colorectal Cancer Incidence: Umbrella Review of Meta-analyses of Prospective Observational Studies.JAMA Netw Open. 2021 Feb 1;4(2):e2037341. doi: 10.1001/jamanetworkopen.2020.37341. JAMA Netw Open. 2021. PMID: 33591366 Free PMC article. Review.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Dietary Patterns and Growth, Size, Body Composition, and/or Risk of Overweight or Obesity: A Systematic Review [Internet].Alexandria (VA): USDA Nutrition Evidence Systematic Review; 2020 Jul. Alexandria (VA): USDA Nutrition Evidence Systematic Review; 2020 Jul. PMID: 35129906 Free Books & Documents. Review.
Cited by
-
Cannabis and cancer: unveiling the potential of a green ally in breast, colorectal, and prostate cancer.J Cannabis Res. 2024 May 16;6(1):24. doi: 10.1186/s42238-024-00233-z. J Cannabis Res. 2024. PMID: 38755733 Free PMC article. Review.
-
Pilot Study on the Locoregional Demographics of Prostate Cancer in River State, Nigeria.Niger Med J. 2022 May 28;62(6):340-345. doi: 10.60787/NMJ-62-6-65. eCollection 2021 Nov-Dec. Niger Med J. 2022. PMID: 38736520 Free PMC article.
-
Protein intake and cancer: an umbrella review of systematic reviews for the evidence-based guideline of the German Nutrition Society.Eur J Nutr. 2024 Apr 21. doi: 10.1007/s00394-024-03380-4. Online ahead of print. Eur J Nutr. 2024. PMID: 38643440 Review.
-
Emerging Trends of Nanomedicines in the Management of Prostate Cancer: Perspectives and Potential Applications.Pharmaceutics. 2024 Feb 20;16(3):297. doi: 10.3390/pharmaceutics16030297. Pharmaceutics. 2024. PMID: 38543191 Free PMC article. Review.
-
Risk factors for prostate cancer: An umbrella review of prospective observational studies and mendelian randomization analyses.PLoS Med. 2024 Mar 15;21(3):e1004362. doi: 10.1371/journal.pmed.1004362. eCollection 2024 Mar. PLoS Med. 2024. PMID: 38489391 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical